Summary
All extracted claims are about pricing/insurance/coupons and online purchasing guidance, and none are supported by the provided FDA-approved prescribing information (all label_support entries are 'absent').
Category Scores
Accurate Statements
Unsupported Statements
Viagra pricing depends on the strength (typically 25 mg, 50 mg, or 100 mg).
No pricing/strength-related statements are provided in the available label sections.
Viagra pricing depends on the number of tablets per prescription.
No pricing/tablet-quantity statements are provided in the available label sections.
Generic sildenafil is much cheaper than brand-name Viagra.
No comparative pricing statements are provided in the available label sections.
The biggest price drivers are brand versus generic.
No pricing driver statements are provided in the available label sections.
Generic sildenafil usually costs less than Viagra.
No comparative pricing statements are provided in the available label sections.
Price drivers include dose and tablet quantity, which change the per-pill cost.
No pricing/dose/quantity statements are provided in the available label sections.
Prices vary by pharmacy and location.
No pricing variability by pharmacy/location statements are provided in the available label sections.
Insurance coverage and copays can affect sildenafil pricing differently than Viagra.
No payer/copay/insurance pricing statements are provided in the available label sections.
Some plans cover sildenafil/generic alternatives differently than they cover brand Viagra.
No insurance coverage statements are provided in the available label sections.
With insurance, a patient usually pays a copay or coinsurance tied to the formulary tier.
No insurance/cost-sharing/formulary statements are provided in the available label sections.
If an insurance plan covers sildenafil/generic alternatives but not brand Viagra, a patient may get a lower price by asking for a generic option.
No insurance coverage/pricing or advice to seek alternatives is provided in the available label sections.
A common alternative for lower out-of-pocket cost is generic sildenafil, which has the same active ingredient as Viagra.
No statements about active ingredient equivalence between brand and generic (or out-of-pocket cost) are provided in the available label sections.
Comparing prices across nearby pharmacies or checking multiple legitimate online pharmacies often helps when generic sildenafil is expensive.
No guidance about comparing pharmacy prices or online pharmacies is provided in the available label sections.
Pharmacy discount cards or manufacturer offers can reduce Viagra price for some people.
No statements about discount cards/manufacturer offers or price reduction are provided in the available label sections.
Whether a coupon applies depends on whether the product is brand or generic, the patient's insurance status, and the specific offer terms.
No coupon/offer/eligibility statements are provided in the available label sections.
Very low prices for online “Viagra” offers can signal products that are not properly regulated.
No regulatory/marketplace warning about online pricing is provided in the available label sections.
Very low prices for online “Viagra” offers can signal products that may not be genuine.
No statements about counterfeit/non-genuine products related to pricing are provided in the available label sections.
When comparing online offers, the medication should be dispensed by licensed pharmacies.
No guidance about licensed pharmacies/dispensing for online purchases is provided in the available label sections.
Online offers should clearly identify the medication (active ingredient, strength, dosage form) and be dispensed under appropriate regulatory oversight.
No statements about online offer content requirements or regulatory oversight for dispensing are provided in the available label sections.
Contradictions
Important Omissions
Safety Assessment
Potential Patient Risk:
Low
The evaluated claims do not describe contraindications, dosing, or clinical safety; however, they are entirely unsupported by the provided label text.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
High |
Recommendation
Not Aligned
Primary Issue
All pricing/insurance/online-purchasing claims are not supported by the provided FDA-approved prescribing information (label sections absent).
Suggested Improvement
Restrict the response to statements explicitly present in the provided FDA-approved prescribing information; remove or qualify non-labeled pricing, insurance/coupon, and online procurement guidance.